Prevalence and molecular correlates of acquired EGFR resistance mutations in non-small cell lung cancer (NSCLC). - Raez LE; Baca Y; Ribeiro JR; Nieva JJ; Mamdani H; Lopes G; Borghaei H; Socinski M; Wozniak AJ; Vanderwalde A; Uribe CC; Sumarriva D; et al. (Expert review of anticancer therapy, 2025)